 |
市場調査レポート
商品コード
1373887
バイオディフェンスの世界市場 (2023-2030年)：タイプ ・用途別の規模・シェア・成長分析・予測Global Biodefense Market Size, Share, Growth Analysis, By Type(Anthrax, Smallpox), By Application(Hospitals and clinics, ambulatory care centres and others) - Industry Forecast 2023-2030 |
||||||
| バイオディフェンスの世界市場 (2023-2030年)：タイプ ・用途別の規模・シェア・成長分析・予測 |
|
出版日: 2023年10月18日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界のバイオディフェンスの市場規模は、2021年の142億7,000万米ドル、2022年の150億米ドルから、予測期間中は5.1％のCAGRで推移し、2030年には223億3,000万米ドルの規模に成長すると予測されています。
世界のバイオディフェンスの市場は、生物製剤による脅威の増大と効果的な準備・対応策の必要性によって、近年著しい成長と変貌を遂げています。バイオディフェンスとは、バイオテロ、パンデミック、その他の生物学的緊急事態に関連する潜在的リスクに対抗することを目的としたさまざまな活動や技術を指し、この市場には、ワクチン、治療薬、検出・診断、防護具など、さまざまな分野が含まれます。
生物学的攻撃や集団発生がもたらす潜在的な大惨事に対する認識が高まっているため、生体防御ソリューションに対する需要が急増しています。世界の政府が生物防御能力に大規模な投資を行っており、市場の成長を後押ししています。さらに、技術の進歩やR&Dへの注力の高まりも革新的で洗練されたバイオディフェンス製品の導入につながっています。ゲノミクス、合成生物学、データ解析などの技術の進歩が生物学的脅威の検出、特性解析、緩和の機能強化を提供し、バイオディフェンスソリューションの進化を促進しています。さらに、政府、防衛機関、民間企業間の連携も包括的なバイオディフェンス戦略の発展を促進し、市場拡大を後押ししています。
当レポートでは、世界のバイオディフェンスの市場を調査し、市場概要、市場への各種影響因子の分析、技術・イノベーションの動向、法規制環境、市場規模の推移・予測、各種区分・地域別の内訳、競合情勢、主要企業のプロファイルなどをまとめています。
目次
- エグゼクティブサマリー
- 調査手法
- 親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 主要な市場洞察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料分析
- イノベーションマトリックス
- パイプライン製品の分析
- マクロ経済指標
- 主要投資分析
- 主要な成功要因
- 競合の程度
- 市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 市場力学
- 規制状況
- ポーターの分析
- 将来のディスラプションに関するSkyquestの特別な洞察
- 世界のバイオディフェンス市場：タイプ別
- 市場概要
- 炭疽菌
- 天然痘
- ボツリヌス症
- 放射線・原子力
- その他
- 世界のバイオディフェンス市場：用途別
- 市場概要
- 病院・診療所
- 外来診療センター
- その他
- 世界のバイオディフェンス市場：地域別
- 市場概要
- 北米
- 欧州
- アジア太平洋
- ラテンアメリカ
- 中東・アフリカ
- 競合情勢
- トップ5社の比較
- 主要企業の市場での位置付け
- 主要企業の採用戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア
- 主要企業プロファイル
- XOMA Corporation
- Altimmune Inc.
- Emergent Biosolutions Inc.
- Dynavax Technologies Corporation
- SIGA Technologies
- Elusys Therapeutics Inc.
- Ichor Medical Systems
- Dynport Vaccine Company
- Cleveland Biolabs
- Bavarian Nordic
- Ology Bioservices
- Alnylam Pharmaceuticals Inc.
- Evolva
- BioCryst Pharmaceuticals Inc.
- PharmAthene Inc.
- Profectus Biosciences Inc.
- NanoViricides Inc.
- Takeda Pharmaceutical Company Limited
- Sanofi Pasteur
- GlaxoSmithKline
Global Biodefense Market size was valued at USD 14.27 billion in 2021 and is poised to grow from USD 15 billion in 2022 to USD 22.33 billion by 2030, growing at a CAGR of 5.1% during the forecast period (2023-2030).
The global biodefense market has witnessed significant growth and transformation in recent years, driven by the increasing threats posed by biological agents and the need for effective preparedness and response measures. Biodefense refers to a range of activities and technologies aimed at countering the potential risks associated with bioterrorism, pandemics, and other biological emergencies. The market encompasses various sectors, including vaccines, therapeutics, detection and diagnostics, and protective equipment. The demand for biodefense solutions has surged due to the growing recognition of the potential catastrophic consequences of biological attacks and outbreaks. Governments around the world are investing heavily in biodefense capabilities, bolstering the market's growth. Additionally, advancements in technology and the increasing focus on research and development have led to the introduction of innovative and sophisticated biodefense products. Technological advancements, including genomics, synthetic biology, and data analytics, are driving the evolution of biodefense solutions, providing enhanced capabilities in detection, characterization, and mitigation of biological threats. Furthermore, collaborations between governments, defense agencies, and private sector entities have fostered the development of comprehensive biodefense strategies and bolstered market expansion.
Top-down and bottom-up approaches were used to estimate and validate the size of the global Biodefense Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Biodefense Market Segmental Analysis
Global Biodefense Market is segmented by type, application, and region. Based on type, the market can be segmented into Anthrax, Smallpox, Botulism, Radiation/Nuclear and Others. Based on application, the market is segmented into Hospitals and clinics, ambulatory care centres and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Biodefense Market Dynamics
Drivers of the Global Biodefense Market
Increasing recognition of the potential catastrophic consequences of biological threats
One key driver of the global biodefense market is the increasing recognition of the potential catastrophic consequences of biological threats. Governments, defense agencies, and healthcare organizations worldwide are investing heavily in biodefense capabilities to mitigate the risks posed by bioterrorism, pandemics, and other biological emergencies.
Restraints in the Global Biodefense Market
High costs associated with research and development of biodefense solutions
A notable restraint for the Global Biodefense Market is the high costs associated with research and development of biodefense solutions. Developing effective vaccines, therapeutics, and detection systems requires substantial investment in research, clinical trials, and regulatory approvals. The complex nature of biodefense threats adds to the challenges, making it difficult to achieve cost-effective solutions and hindering market growth.
Market Trends of the Global Biodefense Key
One key market trend in the global biodefense market is the increasing focus on the development of advanced diagnostic technologies. There is a growing emphasis on the rapid and accurate detection of biological agents to enable early intervention and effective response during biodefense incidents. Innovative diagnostic tools, such as point-of-care testing devices and molecular diagnostics, are being developed to enhance the speed and accuracy of identifying potential biological threats. This trend aims to strengthen surveillance systems and improve the overall preparedness and response capabilities in biodefense scenarios.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Biodefense Market by Type
- Market Overview
- Anthrax
- Smallpox
- Botulism
- Radiation/Nuclear and Others
- Global Biodefense Market by Application
- Market Overview
- Hospitals and clinics
- ambulatory care centres and others
- Global Biodefense Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- XOMA Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Altimmune Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Emergent Biosolutions Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dynavax Technologies Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SIGA Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Elusys Therapeutics Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ichor Medical Systems (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dynport Vaccine Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cleveland Biolabs (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bavarian Nordic (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ology Bioservices (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Alnylam Pharmaceuticals Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Evolva (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioCryst Pharmaceuticals Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PharmAthene Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Profectus Biosciences Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NanoViricides Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi Pasteur (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GlaxoSmithKline (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
